secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2026-03-12T23:59:59+00:00
Accession:  0001636422-26-000031
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst reports Q4 revenue down 6% YoY; net loss widens to $91M
-----------------------------------------------------------------------

- Full-year 2025 revenue $311.1M, up 1% YoY; Q4 revenue $74.7M, down 6% YoY.
- Q4 net loss $91.0M vs $20.7M in Q4 2024; full-year net loss $178.0M vs $69.5M.
- Adjusted EBITDA for full-year 2025 was $41.4M.
- CEO Ben Albert cited opportunities and areas for improvement; focused on long-term success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642226000031/0001636422-26-000031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642226000031/hcat-20260312.htm
  HTML page:      https://secwatch.observer/filing/0001636422-26-000031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer